Galectin Therapeutics Inc. (GALT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$3.09
Day's range
$3.47

Galectin Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
05/15/2026 1.97 M $5.49 M   100.00% 3.08%
MARSHALL WACE, LLP 05/15/2026 1.22 M $3.40 M   102.60% 1.91%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 1.12 M $3.13 M   2.94% 1.76%
GREAT POINT PARTNERS LLC 05/15/2026 800.00 K $2.23 M   100.00% 1.25%
BLACKROCK, INC. 05/13/2026 799.24 K $2.23 M   0.34% 1.25%
MILLENNIUM MANAGEMENT LLC 05/15/2026 798.43 K $2.23 M   239.03% 1.25%
WEALTHSPIRE ADVISORS, LLC 05/01/2026 721.79 K $2.01 M   19.90% 1.13%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 612.79 K $1.71 M   2.46% 0.96%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 555.70 K $1.55 M   93.68% 0.87%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 473.30 K $1.32 M   -8.20% 0.74%
TWO SIGMA INVESTMENTS, LP 05/15/2026 467.06 K $1.30 M   2,711.60% 0.73%
COMMONWEALTH EQUITY SERVICES, LLC 04/27/2026 367.11 K $1.02 M   9.88% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 304.24 K $848.83 K   100.00% 0.48%
CITADEL ADVISORS LLC 05/15/2026 290.36 K $810.10 K   100.00% 0.45%
LPL FINANCIAL LLC 05/06/2026 267.20 K $745.49 K   -17.85% 0.42%
VIVALDI CAPITAL MANAGEMENT LP 05/14/2026 258.58 K $721.45 K   26.71% 0.40%
STATE STREET CORP 05/15/2026 258.43 K $721.03 K   6.69% 0.40%
SOVRAN ADVISORS, LLC 05/01/2026 257.83 K $585.27 K   14.15% 0.40%
GENEOS WEALTH MANAGEMENT INC. 05/05/2026 240.93 K $672.19 K   -0.99% 0.38%
JANE STREET GROUP, LLC 05/12/2026 194.87 K $543.68 K   -2.24% 0.30%
RETIREMENT GUYS FORMULA LLC 04/22/2026 187.06 K $521.90 K   1.35% 0.29%
GOLDMAN SACHS GROUP INC 05/15/2026 184.74 K $515.42 K   -39.87% 0.29%
UBS GROUP AG 05/05/2026 179.74 K $501.48 K   359.65% 0.28%
JANE STREET GROUP, LLC 05/12/2026 167.40 K $467.05 K   -7.15% 0.26%
683 CAPITAL MANAGEMENT, LLC 05/15/2026 162.48 K $453.33 K   0.00% 0.25%
BLAIR WILLIAM & CO/IL 05/08/2026 149.28 K $416.50 K   294.05% 0.23%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 147.90 K $412.64 K   100.00% 0.23%
NORTHERN TRUST CORP 05/14/2026 130.45 K $363.95 K   0.00% 0.20%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 04/30/2026 128.65 K $359.00 K   2.09% 0.20%
QUBE RESEARCH & TECHNOLOGIES LTD 05/15/2026 126.44 K $352.77 K   69.39% 0.20%
BARCLAYS PLC 05/15/2026 111.85 K $312.06 K   5.12% 0.18%
BELPOINTE ASSET MANAGEMENT LLC 04/28/2026 106.14 K $296.13 K   0.00% 0.17%
FORTIS CAPITAL ADVISORS, LLC 04/28/2026 106.14 K $296.13 K   0.00% 0.17%
MORGAN STANLEY 05/15/2026 104.41 K $291.29 K   -62.62% 0.16%
HIGHTOWER ADVISORS, LLC 05/05/2026 93.38 K $260.52 K   5.66% 0.15%
SIMPLEX TRADING, LLC 05/14/2026 84.00 K $234.36 K   1,405.65% 0.13%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 74.73 K $208.49 K   -4.37% 0.12%
GSA CAPITAL PARTNERS LLP 05/08/2026 71.43 K $199.00 K   -29.95% 0.11%
TRUIST FINANCIAL CORP 04/27/2026 68.00 K $189.72 K   0.00% 0.11%
BANK OF AMERICA CORP /DE/ 05/18/2026 53.86 K $150.28 K   114.91% 0.08%
HRT FINANCIAL LP 05/14/2026 51.06 K $142.00 K   100.00% 0.08%
HORIZON KINETICS ASSET MANAGEMENT LLC 05/15/2026 49.23 K $137.34 K   -4.39% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 44.20 K $123.32 K   -44.12% 0.07%
SANCTUARY ADVISORS, LLC 05/05/2026 43.29 K $120.77 K   -5.46% 0.07%
05/14/2026 41.65 K $116.20 K   -13.23% 0.07%
WILEY BROS.-AINTREE CAPITAL, LLC 05/15/2026 41.00 K $114.39 K   100.00% 0.06%
CITADEL ADVISORS LLC 05/15/2026 40.20 K $112.16 K   100.00% 0.06%
CAPTION MANAGEMENT, LLC 05/15/2026 40.00 K $111.60 K   100.00% 0.06%
BREVAN HOWARD CAPITAL MANAGEMENT LP 05/15/2026 35.59 K $99.28 K   100.00% 0.06%
CITADEL ADVISORS LLC 05/15/2026 32.80 K $91.51 K   19.27% 0.05%

Galectin Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 141 institutional investors and hedge funds held shares of Galectin Therapeutics Inc. The most heavily invested institutionals were:

MARSHALL WACE, LLP: 1.22 M

ADVISOR GROUP HOLDINGS, INC.: 1.12 M

BlackRock, Inc.: 799,237

MILLENNIUM MANAGEMENT LLC: 798,434

Wealthspire Advisors, LLC: 721,788

GEODE CAPITAL MANAGEMENT, LLC: 612,786

21.71% of Galectin Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 17.36 M shares in the last 24 months. This purchase volume represents approximately $58.16 M in transactions.